Key points are not available for this paper at this time.
Digital biomarkers are helping to reshape the understanding of health and disease, which will have an impact in how an individual's relationship to the environment is assessed, how research is conducted, and how treatment effectiveness is determined. In particular, this article highlights key activities by the pharmaceutical industry as they explore the utility and relevance of digital biomarkers across the value chain. Lastly, this paper will discuss how digital biomarkers, in conjunction with digital environmental markers, will pave the way for the creation of healthy spaces that more directly improve patient outcomes.
Carlos Rodarte (Thu,) studied this question.